Cargando…

Aripiprazole Plasma Concentrations Delivered from Two 2-Month Long-Acting Injectable Formulations: An Indirect Comparison

Aripiprazole 2-month ready-to-use 960 mg (Ari 2MRTU 960) is a novel long-acting injectable (LAI) formulation of aripiprazole monohydrate for administration once every 2 months, developed for the treatment of schizophrenia or maintenance monotherapy treatment of bipolar I disorder in adults (indicati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harlin, Matthew, Chepke, Craig, Larsen, Frank, Bell Lynum, Karimah S, Chumki, Sanjeda R, Fitzgerald, Heather, Such, Pedro, Madera-McDonough, Jessica, Yildirim, Murat, Panni, Moeen, Saklad, Stephen R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259522/ https://www.ncbi.nlm.nih.gov/pubmed/37313228 http://dx.doi.org/10.2147/NDT.S412357

Ejemplares similares

A Randomized, Open-Label, Multiple-Dose, Parallel-Arm, Pivotal Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Aripiprazole 2-Month Long-Acting Injectable in Adults With Schizophrenia or Bipolar I Disorder
por: Harlin, Matthew, et al.
Publicado: (2023)

Comment on “Aripiprazole Plasma Concentrations Delivered from Two 2-Month Long-Acting Injectable Formulations: An Indirect Comparison” [Letter]
por: Rege, Bhaskar, et al.
Publicado: (2023)

Long-acting formulations delivering aripiprazole: beyond single-value characterizations of steady-state pharmacokinetics
por: McConnell, Scott A, et al.
Publicado: (2017)

Paliperidone palmitate once‐every‐3‐months in adults with early illness schizophrenia
por: Bell Lynum, Karimah S., et al.
Publicado: (2018)

Marijuana Compounds: A Nonconventional Approach to Parkinson's Disease Therapy
por: Babayeva, Mariana, et al.
Publicado: (2016)

Prioritizing Treatment Goals of People Diagnosed with Bipolar I Disorder in the US: Best–Worst Scaling Results
por: Bridges, John F P, et al.
Publicado: (2023)

Plasma concentrations and dosing of 2 long-acting injectable formulations of aripiprazole
por: Salzman, Phyllis M, et al.
Publicado: (2017)

A claims‐based, machine‐learning algorithm to identify patients with pulmonary arterial hypertension
por: Hyde, Bethany, et al.
Publicado: (2023)

Symptomatic stability with aripiprazole once-monthly: efficacy analyses from acute and long-term studies
por: Madera, Jessica J, et al.
Publicado: (2019)

Online Survey of Clinical Practice in Patients with Schizophrenia Treated with Long-Acting Injectable Aripiprazole or Paliperidone Palmitate
por: Such, Pedro, et al.
Publicado: (2021)

Biological conversion of aripiprazole lauroxil - An N-acyloxymethyl aripiprazole prodrug
por: Rohde, Morten, et al.
Publicado: (2014)

The effect of aripiprazole once-monthly on personal and social functioning: post hoc analyses of acute and long-term studies
por: Peters-Strickland, Timothy, et al.
Publicado: (2019)

Chlorine Atoms of an Aripiprazole Molecule Control the Geometry and Motion of Aripiprazole and Deschloro-aripiprazole in Subdomain IIIA of Human Serum Albumin
por: Kawai, Akito, et al.
Publicado: (2022)

Aripiprazole cardiosafety: Is it overestimated?
por: Naguy, Ahmed
Publicado: (2016)

Aripiprazole-induced priapism
por: Trivedi, Satya K., et al.
Publicado: (2016)

Aripiprazole once-monthly as maintenance treatment for bipolar I disorder: a 52-week, multicenter, open-label study
por: Calabrese, Joseph R., et al.
Publicado: (2018)

The Financial Times essential guide to making business presentations: how to deliver a winning message
por: Khan-Panni, Phillip
Publicado: (2012)

TARC: Turkish aripiprazole consensus report- Aripiprazole use and switching from other antipsychotics to aripiprazole- consensus recommendations by a Turkish multidisciplinary panel
por: Veznedaroglu, Baybars, et al.
Publicado: (2018)

Using a knowledge translation program to facilitate guideline‐ and evidence‐based patient management: the PAH‐QuERI Extension Program
por: McLaughlin, Vallerie V., et al.
Publicado: (2022)

Graphic representation of pharmacology: Development of an alternative model
por: Saklad, Stephen R.
Publicado: (2018)

Aripiprazole for late-life schizophrenia
por: Rado, Jeffrey, et al.
Publicado: (2010)

Tardive Dyskinesia: Treatment with Aripiprazole
por: Kang, Na-Ri, et al.
Publicado: (2011)

Review of depot aripiprazole for schizophrenia
por: Motiwala, Farha Bilal, et al.
Publicado: (2013)

Aripiprazole-induced skin rash
por: Nath, Santanu, et al.
Publicado: (2016)

Tardive Dystonia Related with Aripiprazole
por: Kim, Sunghwan, et al.
Publicado: (2017)

Aripiprazole-induced transient myopia
por: Cumurcu, Tongabay, et al.
Publicado: (2019)

S200. COMPARISON BETWEEN LONG-ACTING INJECTABLE ARIPIPRAZOLE VERSUS PALIPERIDONE PALMITATE IN THE TREATMENT OF SCHIZOPHRENIA: SYSTEMATIC REVIEW AND INDIRECT TREATMENT COMPARISON
Publicado: (2020)

Aripiprazole for olanzapine-induced symptomatic hyper prolactinemia
por: Aggarwal, Ashish, et al.
Publicado: (2010)

Effects of a remote, YouTube-delivered exercise intervention on young adults’ physical activity, sedentary behavior, and sleep during the COVID-19 pandemic: Randomized controlled trial
por: McDonough, Daniel J., et al.
Publicado: (2022)

Visible Spectrophotometric Method for the Determination of Aripiprazole in Tablets
por: Jain, R., et al.
Publicado: (2011)

Treating Patients with Aripiprazol: A Safe Gamble?
por: Leal, B., et al.
Publicado: (2022)

Differences in autonomic nervous system activity between long-acting injectable aripiprazole and oral aripiprazole in schizophrenia
por: Hattori, Saki, et al.
Publicado: (2023)

Methodological challenges in indirect treatment comparisons: spotlight on a recent comparison of long-acting injectable aripiprazole versus paliperidone palmitate in the treatment of schizophrenia
por: Singh, Arun, et al.
Publicado: (2018)

Cyber smart: five habits to protect your family, money, and identity from cyber criminals
por: McDonough, Bart R
Publicado: (2018)

Persistent hiccups due to aripiprazole in an adolescent with obsessive compulsive disorder responding to dose reduction and rechallenge
por: Kutuk, Meryem Ozlem, et al.
Publicado: (2016)

Use of the Functioning Assessment Short Test (FAST) in defining functional recovery in bipolar I disorder. Post-hoc analyses of long-term studies of aripiprazole once monthly as maintenance treatment
por: Madera, Jessica, et al.
Publicado: (2019)

Role of aripiprazole in treatment-resistant schizophrenia
por: Mossaheb, Nilufar, et al.
Publicado: (2012)

Aripiprazole monotherapy in an adolescent worsens psychosis
por: Panigrahi, Mahima, et al.
Publicado: (2013)

Aripiprazole for acute mania in an elderly person
por: Bharadwaj, Balaji, et al.
Publicado: (2011)

Worsened hypertension control induced by aripiprazole
por: Yasui-Furukori, Norio, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_n1cuqorh8o57n8acsoe3jc3nk8